Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrice Cagle

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomolecules|November 27, 2021
KCNQ1OT1: An Oncogenic Long Noncoding RNAPatrice Cagle, Qi Qi, Suryakant Niture, et al.
Scientific Reports|March 12, 2021
MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8Xinhong Ge, Suryakant Niture, Minghui Lin, et al.
International Journal of Molecular Medicine|July 15, 2014
Caspase-dependent signaling underlies glioblastoma cell death in response to the fungal metabolite, fusarochromanoneElahe Mahdavian, Monique Marshall, Patrick M Martin, et al.
Scientific Reports|July 7, 2019
MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cellsPatrice Cagle, Suryakant Niture, Anvesha Srivastava, et al.
Cancers|December 10, 2021
Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate CancerPatrice Cagle, Nikia Smith, Timothy O Adekoya, et al.
Scientific Reports|June 17, 2022
Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarksLeslimar Rios-Colon, Juliet Chijioke, Suryakant Niture, et al.
Inorganic Chemistry Communications|January 12, 2016
A novel copper(II) complex identified as a potent drug against colorectal and breast cancer cells and as a poison inhibitor for human topoisomerase IIαShayna Sandhaus, Rosella Taylor, Tiffany Edwards, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomolecules|November 27, 2021
KCNQ1OT1: An Oncogenic Long Noncoding RNAPatrice Cagle, Qi Qi, Suryakant Niture, et al.
Scientific Reports|March 12, 2021
MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8Xinhong Ge, Suryakant Niture, Minghui Lin, et al.
International Journal of Molecular Medicine|July 15, 2014
Caspase-dependent signaling underlies glioblastoma cell death in response to the fungal metabolite, fusarochromanoneElahe Mahdavian, Monique Marshall, Patrick M Martin, et al.
Scientific Reports|July 7, 2019
MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cellsPatrice Cagle, Suryakant Niture, Anvesha Srivastava, et al.
Cancers|December 10, 2021
Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate CancerPatrice Cagle, Nikia Smith, Timothy O Adekoya, et al.
Scientific Reports|June 17, 2022
Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarksLeslimar Rios-Colon, Juliet Chijioke, Suryakant Niture, et al.
Inorganic Chemistry Communications|January 12, 2016
A novel copper(II) complex identified as a potent drug against colorectal and breast cancer cells and as a poison inhibitor for human topoisomerase IIαShayna Sandhaus, Rosella Taylor, Tiffany Edwards, et al.
Pageof 1